عبدالله . ن. . Evaluation of the efficacy of bevacizumab in recurrence metastatic ovarian cancer as a second-line and beyond. Tishreen University Journal -Medical Sciences Series, [S. l.], v. 44, n. 1, p. 49–57, 2022. Disponível em: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12000. Acesso em: 25 apr. 2024.